Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.16%3.05B | 18.03%11.33B | 16.56%2.96B | 11.07%2.74B | 23.74%2.97B | 21.28%2.67B | -17.09%9.6B | 30.19%2.54B | -7.42%2.46B | -27.46%2.4B |
| Cost of revenue | 20.29%9.11B | -18.72%7.58B | ||||||||
| Gross profit | 9.55%2.22B | -10.41%2.03B | ||||||||
| Operating expense | 7.71%908.5M | -2.17%843.5M | ||||||||
| Selling and administrative expenses | ---- | 6.41%650.9M | ---- | ---- | ---- | ---- | -2.38%611.7M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 10.20%259.3M | ---- | ---- | ---- | ---- | -3.33%235.3M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 4.04%391.6M | ---- | ---- | ---- | ---- | -1.77%376.4M | ---- | ---- | ---- |
| Research and development costs | ---- | -58.82%8.4M | ---- | ---- | ---- | ---- | 204.48%20.4M | ---- | ---- | ---- |
| Depreciation and amortization | ---- | 2.23%183.6M | ---- | ---- | ---- | ---- | 6.71%179.6M | ---- | ---- | ---- |
| -Depreciation | ---- | 2.23%183.6M | ---- | ---- | ---- | ---- | 6.71%179.6M | ---- | ---- | ---- |
| Rent and land expenses | ---- | 8.96%7.3M | ---- | ---- | ---- | ---- | --6.7M | ---- | ---- | ---- |
| Other operating expenses | ---- | 44.42%109.9M | ---- | ---- | ---- | ---- | -31.01%76.1M | ---- | ---- | ---- |
| Total other operating income | ---- | 1.18%51.6M | ---- | ---- | ---- | ---- | 2.62%51M | ---- | ---- | ---- |
| Operating profit | 14.05%416.3M | 10.87%1.31B | 1.61%347.2M | 41.26%310.5M | 23.74%2.97B | 37.01%365M | -15.48%1.18B | 584.77%341.7M | 1.85%219.8M | 229.14%2.4B |
| Net non-operating interest income (expenses) | 9.03%-109.8M | 5.76%-27.8M | 11.31%-25.1M | -2.55%-120.7M | -31.7M | -29.5M | -28.3M | |||
| Non-operating interest income | -27.96%6.7M | -22.75%32.6M | -32.74%7.6M | -34.26%7.1M | -22.52%8.6M | 3.33%9.3M | 22.67%42.2M | 48.68%11.3M | 40.26%10.8M | 16.84%11.1M |
| Non-operating interest expense | -14.43%33.2M | -11.97%105.2M | -19.40%32.4M | -13.40%34.9M | -14.47%33.7M | -3.48%38.8M | 0.50%119.5M | 528.13%40.2M | 13.84%40.3M | 1.55%39.4M |
| Total other finance cost | ---- | -14.29%37.2M | ---- | ---- | ---- | ---- | 30.72%43.4M | ---- | ---- | ---- |
| Net investment income | 507.74%300.1M | 89.07%-9.2M | -638.35%-189.5M | 76.28%-73.6M | -30.4M | -84.2M | 35.2M | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | -17.41%24.2M | -87.26%29.3M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 68.15%26.4M | -38.91%15.7M | ||||||||
| Income from associates and other participating interests | -1.07%351.4M | -21.10%61.7M | 85.20%108.9M | 29.49%355.2M | 91.4M | 78.2M | 58.8M | |||
| Special income (charges) | -4,800.00%-37.6M | -96.68%800K | ||||||||
| Less:Impairment of capital assets | ---- | 649.18%45.7M | ---- | ---- | ---- | ---- | 205.00%6.1M | ---- | ---- | ---- |
| Less:Other special charges | ---- | 34.15%-5.4M | ---- | ---- | ---- | ---- | 65.69%-8.2M | ---- | ---- | ---- |
| Less:Write off | ---- | -307.69%-2.7M | ---- | ---- | ---- | ---- | 159.09%1.3M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 27.91%11M | 8.6M | ||||||||
| Income before tax | -39.77%487M | 34.25%1.88B | 19.70%512.9M | 81.88%335.2M | -47.16%220.8M | 119.85%808.6M | -8.36%1.4B | 360.26%428.5M | -29.33%184.3M | -51.24%417.9M |
| Income tax | 25.42%112M | 20.87%341.1M | -4.46%77.2M | 13.86%69M | 34.01%105.6M | 44.03%89.3M | -28.74%282.2M | 53.32%80.8M | 2.19%60.6M | -44.47%78.8M |
| Net income | -47.87%375M | 37.63%1.54B | 25.31%435.7M | 115.20%266.2M | -66.03%115.2M | 135.22%719.3M | -1.21%1.12B | 760.64%347.7M | -38.61%123.7M | -52.58%339.1M |
| Net income continuous operations | -47.87%375M | 37.63%1.54B | 25.31%435.7M | 115.20%266.2M | -66.03%115.2M | 135.22%719.3M | -1.21%1.12B | 760.64%347.7M | -38.61%123.7M | -52.58%339.1M |
| Noncontrolling interests | -34.88%5.6M | 128.99%15.8M | -200.00%-800K | 550.00%3.9M | 10.81%4.1M | 377.78%8.6M | -56.33%6.9M | -75.00%800K | -85.37%600K | 23.33%3.7M |
| Net income attributable to the company | -48.02%369.4M | 37.07%1.52B | 25.83%436.5M | 113.08%262.3M | -66.88%111.1M | 133.78%710.7M | -0.43%1.11B | 832.53%346.9M | -37.64%123.1M | -52.90%335.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -48.02%369.4M | 37.07%1.52B | 25.83%436.5M | 113.08%262.3M | -66.88%111.1M | 133.78%710.7M | -0.43%1.11B | 832.53%346.9M | -37.64%123.1M | -52.90%335.4M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -48.08%0.0595 | 37.08%0.2451 | 25.94%0.0704 | 113.64%0.0423 | -66.91%0.0179 | 133.88%0.1146 | -0.39%0.1788 | 816.39%0.0559 | -37.74%0.0198 | -52.83%0.0541 |
| Diluted earnings per share | -48.08%0.0595 | 37.08%0.2451 | 25.94%0.0704 | 113.64%0.0423 | -66.91%0.0179 | 133.88%0.1146 | -0.39%0.1788 | 816.39%0.0559 | -37.74%0.0198 | -52.83%0.0541 |
| Dividend per share | 10.00%0.055 | 5.26%0.1 | 0 | 11.11%0.05 | 0 | 0.00%0.05 | -32.14%0.095 | 0 | -25.00%0.045 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.